Fusion Pharmaceuticals (FUSN) SEC Filings & 10K Form

$21.51
+0.05 (+0.23%)
(As of 05/17/2024 ET)

Recent Fusion Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/10/2024
6:54 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:00 AM
Fusion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
6:30 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:52 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
6:54 AM
Fusion Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
6:34 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
6:36 AM
Fusion Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
4:02 PM
Fusion Pharmaceuticals (Filer)
Form 8-K/A
04/12/2024
7:00 AM
Fusion Pharmaceuticals (Filer)
Form 10-K/A
04/10/2024
3:42 PM
Fusion Pharmaceuticals (Filer)
Form PREM14A
04/09/2024
3:10 PM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
8:10 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G/A
03/25/2024
4:29 PM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13D
03/20/2024
5:08 PM
Fusion Pharmaceuticals (Subject)
HealthCap VII, L.P. (Filed by)
Form SC 13D/A
03/20/2024
3:30 PM
Fusion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2024
3:10 PM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
3:14 PM
Fusion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2024
4:27 PM
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals (Subject)
Form DFAN14A
03/19/2024
5:24 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
5:25 AM
Fusion Pharmaceuticals (Filer)
Form DEFA14A
02/13/2024
8:34 PM
Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G/A
01/19/2024
3:37 PM
Fusion Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
01/19/2024
3:10 PM
Fusion Pharmaceuticals (Filer)
Form 424B5
01/18/2024
9:11 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G/A
01/05/2024
7:46 AM
Bobilev Dmitri (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
7:49 AM
Fusion Pharmaceuticals (Issuer)
Rawat Mohit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
7:51 AM
Burak Eric (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
7:52 AM
Crowley John J (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
7:54 AM
Fusion Pharmaceuticals (Issuer)
Leamon Christopher P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
7:41 AM
Fusion Pharmaceuticals (Issuer)
Valliant John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:45 PM
Flynn James E (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G
12/14/2023
4:31 PM
Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
4:36 PM
Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2023
7:00 AM
Fusion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:45 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
4:20 PM
Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G
10/16/2023
3:59 PM
Bitetti Teresa Marie (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
4:00 PM
Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
3:48 PM
Bender Jeremy (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
3:51 PM
Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2023
3:30 PM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)

Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …

Click here to see the presentation now.
08/08/2023
7:21 AM
Fusion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
6:30 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
11:15 PM
Fusion Pharmaceuticals (Filer)
Form EFFECT
06/20/2023
7:00 AM
Fusion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2023
4:04 PM
Bergstrom Donald A (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:05 PM
CAGNONI PABLO J (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:06 PM
Duncan Barbara Gayle (Reporting)
Fusion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:07 PM
Fusion Pharmaceuticals (Issuer)
GANNON STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:08 PM
Fusion Pharmaceuticals (Issuer)
Khuong Chau Quang (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:09 PM
Fusion Pharmaceuticals (Issuer)
Lee Philina (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:10 PM
Fusion Pharmaceuticals (Issuer)
Preston Heather (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
7:19 AM
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:FUSN) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners